Clinical Trial Update: Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic [Phase 3]

View source ↗

Summary

A Phase 3 trial compares paclitaxel with and without trastuzumab in breast cancer that is operable but may be recurrent or metastatic, including both HER2-posit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Stage Iiic Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Paclitaxel (Taxol) (paclitaxel)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: HER2-negative Breast Cancer, HER2-positive Breast Cancer | Phase 3 | Status: COMPLETED